Brett P. GIROIR,Clifford H. KERN, III,Carola LEUSCHNER
申请号：
US16209143
公开号：
US20190241660A1
申请日:
2018.12.04
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Presented herein are immune-stimulating peptides and uses thereof for treating cancer. The immune-stimulating peptides can be used alone, or in combination with checkpoint inhibitors and other anti-cancer therapies. The immune-stimulating peptides can also be used for expanding T-cells in vitro or ex vivo, which expanded T-cells can then be used for adoptive cell therapy.
